Schedule 13D ownership disclosure
Celator Pharmaceuticals Inc
Security class unavailable · CUSIP: 15089R102
Event date: 2016-07-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 0
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-16-014203
- Form type
- SC 13D
- Filer
- CAXTON CORP
- CIK
- CIK 1388551
- Filed
- Jul 15, 2016
- Reporting period
- Jul 12, 2016
- Description
- Schedule 13D beneficial ownership